Newtyn Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-250,000
Closed -$23.1M 55
2019
Q4
$23.1M Buy
250,000
+100,000
+67% +$8.79M 2.14% 10
2019
Q3
$13.6M Hold
150,000
1.28% 21
2019
Q2
$17.7M Hold
150,000
2.29% 14
2019
Q1
$13M Sell
150,000
-318,828
-68% -$27.1M 2.46% 15
2018
Q4
$29.6M Buy
468,828
+318,828
+213% +$21.9M 5.79% 6
2018
Q3
$11.8M Hold
150,000
2.03% 17
2018
Q2
$8.97M Buy
+150,000
New +$8.07M 1.68% 15

Other funds holding EXAS

Newtyn Management's EXAS Position: Q1 2020 in Review

Newtyn Management sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 250,000 shares — an estimated $23.1M sold.

Newtyn Management first reported a position in EXAS in Q2 2018 and held it in 7 quarters. The position peaked at $29.6M in Q4 2018. 475 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Newtyn Management reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
  • Newtyn Management sold 250,000 Exact Sciences shares in Q1 2020, an estimated $23.1M.
  • Newtyn Management first reported a position in Exact Sciences in Q2 2018 and held it in 7 quarters.
  • Newtyn Management's Exact Sciences position peaked at $29.6M in Q4 2018.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Newtyn Management's 13F filing for Q1 2020, filed 15 May 2020.